Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Novo Nordisk |
---|---|
Information provided by: | Novo Nordisk |
ClinicalTrials.gov Identifier: | NCT00849342 |
This study is conducted in Europe. The aim of this observational study is to investigate the effect of switch from other basal insulin treatments to Levemir® on body weight in obese diabetic patients.
Condition | Intervention |
---|---|
Diabetes Mellitus |
Drug: insulin detemir |
Study Type: | Observational |
Study Design: | Case-Only, Prospective |
Official Title: | A Prospective, Multicentre, Non-controlled, Observational, 52-weeks Study: the Evaluation of the Body Weight Progress During the Treatment With Insulin Detemir in Type 1 or 2 Diabetes Patients, Previously Treated With Other Basal Insulins. |
Estimated Enrollment: | 200 |
Study Start Date: | January 2009 |
Estimated Study Completion Date: | November 2010 |
Estimated Primary Completion Date: | November 2010 (Final data collection date for primary outcome measure) |
Groups/Cohorts | Assigned Interventions |
---|---|
A |
Drug: insulin detemir
Safety and effectiveness(weight and HbA1c) data collection in connection with the use of the drug Levemir® in daily clinical practice.
|
Ages Eligible for Study: | 6 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Patients from both general and speciality practice settings who have been deemed appropriate to receive Levemir® because of weight increase on other insulin therapies, and as part of routine out-patient care by the prescribing physician.
Inclusion Criteria:
Exclusion Criteria:
Contact: Public Access to Clinical Trials - Novo Nordisk | Please Contact NN via email | clinicaltrials@novonordisk.com |
Netherlands | |
Recruiting | |
Alphen a/d Rijn, Netherlands |
Study Director: | Sarita Kesarlal, MSc | Novo Nordisk B.V. |
Study Director: | Piet van der Wal, MD,phD | Novo Nordisk B.V. |
Responsible Party: | Novo Nordisk A/S ( Public Access to Clinical Trials ) |
Study ID Numbers: | NN304-3708 |
Study First Received: | February 20, 2009 |
Last Updated: | August 18, 2009 |
ClinicalTrials.gov Identifier: | NCT00849342 History of Changes |
Health Authority: | Netherlands: Medicines Evaluation Board, Dutch Health Care Inspectorate |
Body Weight Obesity Hypoglycemic Agents Metabolic Diseases Diabetes Mellitus |
Endocrine System Diseases Endocrinopathy Glucose Metabolism Disorders Metabolic Disorder Insulin |
Hypoglycemic Agents Metabolic Diseases Physiological Effects of Drugs Diabetes Mellitus |
Endocrine System Diseases Glucose Metabolism Disorders Pharmacologic Actions Insulin |